Biotech Market Intelligence & Analysis
In-depth articles on the biotech landscape — market analysis, sector reports, funding trends, and company spotlights.
Biotech Funding Roundup: March 23-27, 2026
This week's biotech funding activity — real deals, real numbers, all sourced from verified reporting.
The 20 Most Active Biotech Investors in 2026
The biotech venture capital landscape in 2026 is not merely concentrated; it is fundamentally bifurcated. Publicly available deal data reveals two parallel systems of capital allocation operating at massive scale. The first is the visible, meticulous world of public science funding, where National I
Where is Biotech VC Money Going in 2026?
The first quarter of 2026 presents a biotech funding environment of substantial, yet strategically focused, capital deployment. An analysis of 200 tracked financing rounds reveals a total of $26.8 billion invested across the global ecosystem. This figure, while significant, suggests a continuation o
Biotech Funding in 2026: Where VCs Are Investing
As we reach the midpoint of 2026, the biotech venture funding landscape is defined by a powerful dichotomy: immense pools of capital are available, but their deployment is more disciplined and concentrated than ever before. The era of "spray and pray" investing is firmly in the r